WADA pairs with pharmaceutical giant for doping detection

WADA president John Fahey gives an address at a symposium in Lausanne, Switzerland.

WADA president John Fahey gives an address at a symposium in Lausanne, Switzerland. (Image credit: AFP Photo)

The World Anti-Doping Agency (WADA) announced today that it has signed a long-term agreement with pharmaceutical giant GlaxoSmithKline to get assistance in its efforts to stay on top of detection methods for emerging performance-enhancing drugs.